This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Resources

NUBEQA® (darolutamide) Resources

NUBEQA® (darolutamide)
nmCRPC case study

nmCRPC case study

mHSPC case study

mHSPC case study

Patient leaflet

Patient leaflet

nmCRPC checklist

nmCRPC checklist

mHSPC checklist

mHSPC checklist

PP-NUB-GB-2048 | February 2025